SECTM1 Antibody (01) [mFluor Violet 610 SE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05807MFV610
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
mFluor Violet 610 SE (Excitation = 421 nm, Emission = 613 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 01
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human SECTM1 (Uniprot#: Q8WVN6-1; Met1-Gly145).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for SECTM1 Antibody (01) [mFluor Violet 610 SE]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SECTM1
Long Name
Secreted and Transmembrane 1
Alternate Names
CD7 Ligand, Protein K12
Gene Symbol
SECTM1
Additional SECTM1 Products
Product Documents for SECTM1 Antibody (01) [mFluor Violet 610 SE]
Product Specific Notices for SECTM1 Antibody (01) [mFluor Violet 610 SE]
mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...